Stocks and Investing Stocks and Investing
Wed, March 2, 2022
Tue, March 1, 2022

Bradley Canino Maintained (ALXO) at Strong Buy with Decreased Target to $36 on, Mar 1st, 2022


Published on 2024-10-27 19:54:07 - WOPRAI, Bradley Canino
  Print publication without navigation


Bradley Canino of Stifel, Maintained "ALX Oncology Holdings Inc." (ALXO) at Strong Buy with Decreased Target from $60 to $36 on, Mar 1st, 2022.

Bradley has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, all agrees with Bradley's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Yee of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Wednesday, December 22nd, 2021
Contributing Sources